AI-generated summary
The authors studied 808 nm photobiomodulation at three energy densities in mice with nerve-constriction neuropathic pain over 90 days. They report that the 20 and 40 J/cm2 groups showed improved pain thresholds from day 30, and that these groups had significant increases in blood beta-endorphin. The authors conclude that higher energy densities were more effective.
- Participants
- 50
- Who or what was studied
- Mice with neuropathic pain induced by chronic constriction injury of the sciatic nerve
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The study was conducted in mice, and the abstract does not describe the statistical methods or report effect sizes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
- Energy density (fluence)
- 40 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Neuropathy, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.